Penn Medicine Provider
Neurology
Whitley Aamodt, MD, MPH
5.0
(269)
Accepting new patients
Sees patients age 18 and up
Penn Neurology Pennsylvania Hospital

About me

  • Assistant Professor of Neurology at the Hospital of the University of Pennsylvania

Education and training

  • Medical School: University of Texas in San Antonio
  • Residency: Baylor College of Medicine/Texas Children's Hospital
  • Residency: Hospital of the University of Pennsylvania

What my patients think about me

Average Rating
5.0

269 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

May 2025
5.0
5.0
would highly recommend her
May 2025
5.0
5.0
I have already recommended her to a friend
April 2025
5.0
5.0
very well informed on up to date info.
April 2025
5.0
5.0
i always have a positive experience.

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Aamodt is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Aamodt W, Kluger B, Mirham M, Job A, Lettenberger S, Mosley P, Seshadri S. Caregiver Burden in Parkinson Disease: A Scoping Review of the Literature from 2017-2022 , J Geriatr Psychiatry Neuro, 37(2): 2023,96-113


Aamodt WW, Bilker WB, Willis AW, Farrar JT. Sociodemographic and Geographic Disparities in End-of-Life Health Care Intensity Among Medicare Beneficiaries With Parkinson Disease , Neurol Clin Pract, 13(4): 2023,e200171


Aamodt WW, Willis AW, Dahodwala N. Racial and Ethnic Disparities in Parkinson Disease: A Call to Action , Neurol Clin Pract, 13(2): 2023,e200138


Aamodt WW, Dubroff JG, Cheng G, Taylor B, Wood S, Duda JE, Morley JF. Gait Abnormalities and Non-Motor Symptoms Predict Abnormal Dopaminergic Imaging in Presumed Drug-Induced Parkinsonism , NPJ Parkinsons Dis, 8(1): 2022,53


Aamodt WW, Waligorska T, Shen J, Tropea TF, Siderowf A, Weintraub D, Grossman M, Irwin D, Wolk DA, Xie SX, Trojanowski JQ, Shaw LM, Chen-Plotkin AS. Neurofilament Light Chain as a Biomarker for Cognitive Decline in Parkinson Disease , Mov Disord, 36(12): 2021,2945-2950


Aamodt WW, Travers J, Thibault D, Willis AW. Hospital Magnet Status Associates With Inpatient Safety in Parkinson Disease , J Neurosci Nurs, 53(3): 2021,116-122


Terracina KA, Aamodt WW, Schillerstrom JE. Executive Function Impairment and Recidivism in Adult Protective Services Clients Referred for a Decision Making Capacity Assessment , J Elder Abuse Negl, 27(2): 2015,91-9


Aamodt WW, Terracina KA, Schillerstrom JE. Cognitive Profiles of Elder Adult Protective Services Clients Living in Squalor , J Elder Abuse Negl, 27(1): 2015,65-73


Park DC, Lodi-Smith J, Drew L, Haber S, Hebrank A, Bischof GN, Aamodt W. The Impact of Sustained Engagement on Cognitive Function in Older Adults: The Synapse Project , Psychol Sci, 27(2): 2014,91-9


View all publications